Last Updated on January 4, 2024 by The Health Master
US Food and Drug Administration (USFDA) issued a Form 483 for Alembic Pharma’s Karkahadi plant in Gujarat.
10 observations on Form 483 issued by the US regulator after its inspection at Alembic Pharma from October 28-November 10.
The regulator largely observed that the plant had not established control procedures and processes with respect to cleaning and maintenance were inadequate.
The USFDA also said the procedures to prevent microbiological contamination were inadequate and that the plant did not maintain written records of investigations into unexplained discrepancies.
FDA Haryana and police unearthed a unit manufacturing spurious cosmetics
In-service Pharmacists authorised to dispense drugs for these 8 common ailments
Recruitment of 87 Drug Inspectors put on hold in Maharashtra
Indian Pharma Industry can meet requirements of the World
10th Gujarat Global Summit 2022 will be held from 10-12 January…
NPPA fixes retail price of Torrent’s FDC Atorvastatin, Clopidogrel Bisulphate, Aspirin
NDPS: 9 arrested for selling drugs
Drug recall: Lupin recalls 4,113 cartons of oral contraceptive
Procedure for registration of Medical Devices: CDSCO
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
